Search

Your search keyword '"Hamid, Qutayba"' showing total 1,868 results
Start Over Author "Hamid, Qutayba"
1,868 results on '"Hamid, Qutayba"'

1. Epidemiological and Clinical Characteristics Associated with COVID-19 Severity Among Hospitalized Patients in the United Arab Emirates: A Retrospective Multicentre Study

Author

Al-Bluwi, Najlaa, Agha, Razan, Shukla, Ankita, Zeidan, Rouba Karen, AlZubaidi, Hamzah, Awad, Manal, Hussein, Amal, Abdelbagi, Muzan, AlSayed, Khaled, Alebaji, Mohamad B., Shaheen, Mahasin, Salameh, Laila, Mahboub, Bassam, Elkhodary, Hady, Bendardaf, Riyad, Mohammed, Ghada, Wardat, Dima, Al-Hano, Zahraa, Amara, Hajir I., Alhajjaj, Mohamed Saleh, Hamid, Qutayba, Halwani, Rabih, and Saddik, Basema

Published
2024
Full Text
View/download PDF

2. Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation

Author

Bourbeau, Jean, Tan, Wan C., FitzGerald, J. Mark, Sin, Don D., Marciniuk, Darcy D., O’Donnell, Denis E., Hernandez, Paul, Chapman, Kenneth R., Walker, Brandie, Aaron, Shawn, Maltais, François, Samet, Jonathon, Puhan, Milo, Hamid, Qutayba, Hogg, James C., Doiron, Dany, Mancino, Palmina, Li, Pei Zhi, Jensen, Dennis, Baglole, Carolyn, Fortier, Yvan, Sin, Don, Yang, Julia, Road, Jeremy, Comeau, Joe, Png, Adrian, Johnson, Kyle, Coxson, Harvey, Leipsic, Jonathon, Hague, Cameron, Kirby, Miranda, Sadatsafavi, Mohsen, To, Teresa, Gershon, Andrea, Li, Pei-Zhi, Song, Zhi, Benedetti, Andrea, Lo, Christine, Cheng, Sarah, Un, Elena, Fung, Cynthia, Wang, Wen Tiang, Zheng, Liyun, Faroon, Faize, Radivojevic, Olga, Chung, Sally, Zou, Carl, Baril, Jacinthe, Labonte, Laura, Chapman, Kenneth, McClean, Patricia, Audisho, Nadeen, Dumonceaux, Curtis, Machado, Lisette, Fulton, Scott, Osterling, Kristen, Wigerius, Denise, Vandemheen, Kathy, Pratt, Gay, Bergeron, Amanda, O’Donnell, Denis, McNeil, Matthew, Whelan, Kate, Brouillard, Cynthia, Marciniuk, Darcy, Clemens, Ron, Baran, Janet, Leuschen, Candice, Ekström, Magnus, and Lewthwaite, Hayley

Published
2024
Full Text
View/download PDF

3. Identifying Abnormal Exertional Breathlessness in COPD: Comparing Modified Medical Research Council and COPD Assessment Test With Cardiopulmonary Exercise Testing

Author

FitzGerald, J. Mark, Sin, Don D., Marciniuk, Darcy D., O’Donnell, Denis E., Hernandez, Paul, Chapman, Kenneth R., Walker, Brandie, Aaron, Shawn, Maltais, François, Samet, Jonathon, Puhan, Milo, Hamid, Qutayba, Hogg, James C., Doiron, Dany, Mancino, Palmina, Li, Pei Zhi, Jensen, Dennis, Baglole, Carolyn, Fortier, Yvan, Sin, Don, Yang, Julia, Road, Jeremy, Comeau, Joe, Png, Adrian, Johnson, Kyle, Coxson, Harvey, Leipsic, Jonathon, Hague, Cameron, Kirby, Miranda, Sadatsafavi, Mohsen, To, Teresa, Gershon, Andrea, Song, Zhi, Benedetti, Andrea, Lo, Christine, Cheng, Sarah, Un, Elena, Fung, Cynthia, Wang, Wen Tiang, Zheng, Liyun, Faroon, Faize, Radivojevic, Olga, Chung, Sally, Zou, Carl, Baril, Jacinthe, Labonte, Laura, Chapman, Kenneth, McClean, Patricia, Audisho, Nadeen, Dumonceaux, Curtis, Machado, Lisette, Fulton, Scott, Osterling, Kristen, Wigerius, Denise, Vandemheen, Kathy, Pratt, Gay, Bergeron, Amanda, O’Donnell, Denis, McNeil, Matthew, Whelan, Kate, Brouillard, Cynthia, Marciniuk, Darcy, Clemens, Ron, Baran, Janet, Leuschen, Candice, Ekström, Magnus, Lewthwaite, Hayley, Bourbeau, Jean, and Tan, Wan C.

Published
2024
Full Text
View/download PDF

4. Impaired Sleep Quality in COPD Is Associated With Exacerbations The CanCOLD Cohort Study

Author

Shorofsky, Matthew, Bourbeau, Jean, Kimoff, John, Jen, Rachel, Malhotra, Atul, Ayas, Najib, Tan, Wan C, Aaron, Shawn D, Sin, Don D, Road, Jeremy, Chapman, Kenneth R, O’Donnell, Denis E, Maltais, François, Hernandez, Paul, Walker, Brandie L, Marciniuk, Darcy, Kaminska, Marta, FitzGerald, J Mark, Sin, DD, Marciniuk, DD, O'Donnell, DE, Cowie, Robert, Aaron, Shawn, Maltais, F, Samet, Jonathon, Puhan, Milo, Hamid, Qutayba, Hogg, James C, Baglole, Carole, Jabet, Carole, Mancino, Palmina, Fortier, Yvan, Sin, Don, Tam, Sheena, Comeau, Joe, Png, Adrian, Coxson, Harvey, Kirby, Miranda, Leipsic, Jonathon, Hague, Cameron, Sadatsafavi, Mohsen, Gershon, Andrea, Li, Pei-Zhi, Duquette, Jean-Francois, Benedetti, Andrea, Jensen, Denis, O'Donnell, Denis, Lo, Christine, Cheng, Sarah, Fung, Cindy, Ferguson, Nancy, Haynes, Nancy, Chuang, Li, Licong, Bayat, Selva, Wong, Amanda, Alavi, Zoe, Peng, Catherine, Zhao, Bin, Scott-Hsiung, Nathalie, Nadirshaw, Tasha, Latreille, David, Baril, Jacinthe, Labonte, Laura, Chapman, Kenneth, McClean, Patricia, Audisho, Nadeen, Walker, Brandie, Cowie, Ann, Dumonceaux, Curtis, Machado, Lisette, Fulton, Scott, Osterling, Kristen, Vandemheen, Kathy, Pratt, Gay, Bergeron, Amanda, McNeil, Matthew, Whelan, Kate, Maltais, Francois, Brouillard, Cynthia, and Clemens, Ron

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Clinical Sciences, Sleep Research, Lung, Behavioral and Social Science, Clinical Research, Chronic Obstructive Pulmonary Disease, Respiratory, Aged, Cohort Studies, Disease Progression, Dyspnea, Female, Health Services, Humans, Male, Middle Aged, Proportional Hazards Models, Prospective Studies, Pulmonary Disease, Chronic Obstructive, Sleep, Sleep Wake Disorders, Sputum, Time Factors, acute exacerbation of chronic bronchitis, COPD, sleep medicine, Canadian Respiratory Research Network, CanCOLD Collaborative Research group, Respiratory System, Cardiovascular medicine and haematology, Clinical sciences
Abstract

BackgroundCOPD increases susceptibility to sleep disturbances, which may in turn predispose to increased respiratory symptoms. The objective of this study was to evaluate, in a population-based sample, the relationship between subjective sleep quality and risk of COPD exacerbations.MethodsData were obtained from the Canadian Cohort Obstructive Lung Disease (CanCOLD) study. Participants with COPD who had completed 18 months of follow-up were included. Sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI) and a three-factor analysis. Symptom-based (dyspnea or sputum change ≥ 48 h) and event-based (symptoms plus medication or unscheduled health services use) exacerbations were assessed. Association of PSQI with exacerbation rate was assessed by using negative binomial regression. Exacerbation-free survival was also assessed.ResultsA total of 480 participants with COPD were studied, including 185 with one or more exacerbations during follow-up and 203 with poor baseline sleep quality (PSQI score > 5). Participants with subsequent symptom-based exacerbations had higher median baseline PSQI scores than those without (6.0 [interquartile range, 3.0-8.0] vs 5.0 [interquartile range, 2.0-7.0]; P = .01), and they were more likely to have baseline PSQI scores > 5 (50.3% vs 37.3%; P = .01). Higher PSQI scores were associated with increased symptom-based exacerbation risk (adjusted rate ratio, 1.09; 95% CI, 1.01-1.18; P = .02) and event-based exacerbation risk (adjusted rate ratio, 1.10; 95% CI, 1.00-1.21; P = .048). The association occurred mainly in those with undiagnosed COPD. Strongest associations were with Factor 3 (sleep disturbances and daytime dysfunction). Time to symptom-based exacerbation was shorter in participants with poor sleep quality (adjusted hazard ratio, 1.49; 95% CI, 1.09-2.03).ConclusionsHigher baseline PSQI scores were associated with increased risk of COPD exacerbation over 18 months' prospective follow-up.

Published
2019

12. Association of specific ACE2 and TMPRSS2 variants with circulatory cytokines of COVID-19 Emirati patients

Author

Elemam, Noha M., primary, Bouzid, Amal, additional, Alsafar, Habiba, additional, Ahmed, Samrein BM, additional, Hafezi, Shirin, additional, Venkatachalam, Thenmozhi, additional, Eldohaji, Leen, additional, Al Hamidi, Tasneem, additional, Gerges, Peter Habib, additional, Halabi, Nour, additional, Hadj-Kacem, Hassen, additional, Talaat, Iman M., additional, Taneera, Jalal, additional, Sulaiman, Nabil, additional, Maghazachi, Azzam A., additional, Hamid, Qutayba, additional, Hamoudi, Rifat, additional, and Saber-Ayad, Maha, additional

Published
2024
Full Text
View/download PDF

17. Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype.

Author

Ansari, Abdul Wahid, Jayakumar, Manju Nidagodu, Ahmad, Fareed, Venkatachalam, Thenmozhi, Salameh, Laila, Unnikannan, Hema, Raheed, Thesni, Mohammed, Abdul Khader, Mahboub, Bassam, Al-Ramadi, Basel K., Hamid, Qutayba, Steinhoff, Martin, and Hamoudi, Rifat

Subjects
MONONUCLEAR leukocytes, CELLULAR immunity, RESPIRATORY infections, LYMPHOPROLIFERATIVE disorders, MACROLIDE antibiotics
Abstract

Macrolide antibiotic azithromycin is widely used in clinical practice to treat respiratory tract infections and inflammatory diseases. However, its mechanism of action is not fully understood. Given the involvement of the CD27 pathway in the pathophysiology of various T-lymphocyte-mediated inflammatory, autoimmune, and lymphoproliferative diseases, we examined the impact of AZM on CD27 regulation and potential consequences on CD4+ and CD8+ T-cell phenotypes. Using cellular immunology approaches on healthy donors' peripheral blood mononuclear cells, we demonstrate AZM-mediated downregulation of surface CD27 expression as well as its extracellular release as soluble CD27. Notably, AZM-exposed CD27high (hi) cells were defective in their ability to expand compared to CD27intermediate (Int) and CD27low (lo) subsets. The defective CD27hi subset expansion was found to be associated with impaired cell proliferation and cell division. At the molecular level, the CD27hi subset exhibited lower mTOR activity than other subsets. Functionally, AZM treatment resulted in marked depletion of helper CD4+ (Th1) and cytotoxic CD8+ T-lymphocyte (Tc1)-associated CXCR3+CD27hi effector cells and inhibition of inflammatory cytokine IFN-g production. These findings provide mechanistic insights on immunomodulatory features of AZM on T-lymphocyte by altering the CD27 pathway. From a clinical perspective, this study also sheds light on potential clinical benefits observed in patients on prophylactic AZM regimens against various respiratory diseases and opens avenues for future adjunct therapy against Th1- and Tc1-dominated inflammatory and autoimmune diseases. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. Role of IL‐5 in asthma and airway remodelling.

Author

AbuJabal, Rola, Ramakrishnan, Rakhee K., Bajbouj, Khuloud, and Hamid, Qutayba

Subjects
ASTHMATICS, DRUG target, TISSUE remodeling, BIOTHERAPY, THERAPEUTICS
Abstract

Asthma is a common and burdensome chronic inflammatory airway disease that affects both children and adults. One of the main concerns with asthma is the manifestation of irreversible tissue remodelling of the airways due to the chronic inflammatory environment that eventually disrupts the whole structure of the airways. Most people with troublesome asthma are treated with inhaled corticosteroids. However, the development of steroid resistance is a commonly encountered issue, necessitating other treatment options for these patients. Biological therapies are a promising therapeutic approach for people with steroid‐resistant asthma. Interleukin 5 is recently gaining a lot of attention as a biological target relevant to the tissue remodelling process. Since IL‐5‐neutralizing monoclonal antibodies (mepolizumab, reslizumab and benralizumab) are currently available for clinical use, this review aims to revisit the role of IL‐5 in asthma pathogenesis at large and airway remodelling in particular, in addition to exploring its role as a target for biological treatments. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

19. Sex‐related differences in pulmonary vascular volume distribution.

Author

Wright, Stephen P., Kirby, Miranda, Singh, Gaurav V., Tan, Wan C., Bourbeau, Jean, Eves, Neil D., Samet, Jonathon, Puhan, Milo, Hamid, Qutayba, Baglole, Carolyn, Mancino, Palmina, Li, Pei‐Zhi, Song, Zhi, Jensen, Dennis, Smith, Benjamin Mcdonald, Fortier, Yvan, Dligui, Mina, Chapman, Kenneth, Duke, Jane, and Gershon, Andrea S.

Subjects
PULMONARY arterial hypertension, PULMONARY circulation, LUNG volume, SEXUAL dimorphism, COMPUTED tomography
Abstract

Pulmonary arterial hypertension affects females more frequently than males, and there are known sex‐related differences in the lungs. However, normal sex‐related differences in pulmonary vascular structure remain incompletely described. We aimed to contrast computed tomography‐derived pulmonary vascular volume and its distribution within the lungs of healthy adult females and males. From the CanCOLD Study, we retrospectively identified healthy never‐smokers. We analyzed full‐inspiration computed tomography images, using vessel and airway segmentation to generate pulmonary vessel volume, vessel counts, and airway counts. Vessels were classified by cross‐sectional area >10, 5–10, and <5 mm2 into bins, with volume summed within each area bin and in total. We included 46 females and 36 males (62 ± 9 years old). Females had lower total lung volume, total airway counts, total vessel counts, and total vessel volume (117 ± 31 vs. 164 ± 28 mL) versus males (all p < 0.001). Females also had lower vessel volume >10 mm2 (14 ± 8 vs. 27 ± 9 mL), vessel volume 5–10 mm2 (35 ± 11 vs. 55 ± 10 mL), and vessel volume <5 mm2 (68 ± 18 vs. 82 ± 19 mL) (all p < 0.001). Normalized to total vessel volume, vessel volume >10 mm2 (11 ± 4 vs. 16 ± 4%, p < 0.001) and 5–10 mm2 (30 ± 6 vs. 34 ± 5%, p = 0.001) remained lower in females but vessel volume <5 mm2 relative to total volume was 18% higher (59 ± 8 vs. 50 ± 7%, p < 0.001). Among healthy older adults, pulmonary vessel volume is distributed into smaller vessels in females versus males. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

22. Airway tree caliber heterogeneity and airflow obstruction among older adults

Author

Vameghestahbanati, Motahareh, primary, Kingdom, Leina, additional, Hoffman, Eric A., additional, Kirby, Miranda, additional, Allen, Norrina B., additional, Angelini, Elsa, additional, Bertoni, Alain, additional, Hamid, Qutayba, additional, Hogg, James C., additional, Jacobs, David R., additional, Laine, Andrew, additional, Maltais, François, additional, Michos, Erin D., additional, Sack, Coralynn, additional, Sin, Don, additional, Watson, Karol E., additional, Wysoczanksi, Artur, additional, Couper, David, additional, Cooper, Christopher, additional, Han, MeiLan, additional, Woodruff, Prescott, additional, Tan, Wan C., additional, Bourbeau, Jean, additional, Barr, R. Graham, additional, and Smith, Benjamin M., additional

Published
2024
Full Text
View/download PDF

23. Normative Reference Equations for Breathlessness Intensity during Incremental Cardiopulmonary Cycle Exercise Testing

Author

Ekström, Magnus, primary, Li, Pei Zhi, additional, Lewthwaite, Hayley, additional, Bourbeau, Jean, additional, Tan, Wan C., additional, Schiöler, Linus, additional, Brotto, Andrew, additional, Stickland, Michael K., additional, Jensen, Dennis, additional, FitzGerald, J. Mark, additional, Sin, Don D., additional, Marciniuk, Darcy D., additional, O’Donnell, Denis E., additional, Hernandez, Paul, additional, Chapman, Kenneth R., additional, Walker, Brandie, additional, Aaron, Shawn, additional, Maltais, François, additional, Samet, Jonathon, additional, Puhan, Milo, additional, Hamid, Qutayba, additional, Hogg, James C., additional, Doiron, Dany, additional, Mancino, Palmina, additional, Baglole, Carolyn, additional, Fortier, Yvan, additional, Yang, Julia, additional, Road, Jeremy, additional, Comeau, Joe, additional, Png, Adrian, additional, Johnson, Kyle, additional, Coxson, Harvey, additional, Leipsic, Jonathon, additional, Hague, Cameron, additional, Kirby, Miranda, additional, Sadatsafavi, Mohsen, additional, To, Teresa, additional, Gershon, Andrea, additional, Song, Zhi, additional, Benedetti, Andrea, additional, Lo, Christine, additional, Cheng, Sarah, additional, Un, Elena, additional, Fung, Cynthia, additional, Wang, Wen Tiang, additional, Zheng, Liyun, additional, Faroon, Faize, additional, Radivojevic, Olga, additional, Chung, Sally, additional, Zou, Carl, additional, Baril, Jacinthe, additional, Labonte, Laura, additional, McClean, Patricia, additional, Audisho, Nadeen, additional, Dumonceaux, Curtis, additional, Machado, Lisette, additional, Fulton, Scott, additional, Osterling, Kristen, additional, Wigerius, Denise, additional, Vandemheen, Kathy, additional, Pratt, Gay, additional, Bergeron, Amanda, additional, McNeil, Matthew, additional, Whelan, Kate, additional, Brouillard, Cynthia, additional, Clemens, Ron, additional, Baran, Janet, additional, and Leuschen, Candice, additional

Published
2024
Full Text
View/download PDF

24. GSDMB induces an asthma phenotype characterized by increased airway responsiveness and remodeling without lung inflammation

Author

Das, Sudipta, Miller, Marina, Beppu, Andrew K, Mueller, James, McGeough, Matthew D, Vuong, Christine, Karta, Maya R, Rosenthal, Peter, Chouiali, Fazila, Doherty, Taylor A, Kurten, Richard C, Hamid, Qutayba, Hoffman, Hal M, and Broide, David H

Subjects
Genetics, Lung, Asthma, Aetiology, 2.1 Biological and endogenous factors, Respiratory, Airway Remodeling, Animals, Antigens, Dermatophagoides, Arachidonate 5-Lipoxygenase, Bronchial Hyperreactivity, Cells, Cultured, Collagen, Cytokines, Epithelial Cells, Humans, Matrix Metalloproteinase 9, Mice, Transgenic, Neoplasm Proteins, Phenotype, RNA, Messenger, Respiratory Mucosa, GSDMB, asthma, airway-hyperresponsiveness, remodeling, inflammation
Abstract

Gasdermin B (GSDMB) on chromosome 17q21 demonstrates a strong genetic linkage to asthma, but its function in asthma is unknown. Here we identified that GSDMB is highly expressed in lung bronchial epithelium in human asthma. Overexpression of GSDMB in primary human bronchial epithelium increased expression of genes important to both airway remodeling [TGF-β1, 5-lipoxygenase (5-LO)] and airway-hyperresponsiveness (AHR) (5-LO). Interestingly, hGSDMBZp3-Cre mice expressing increased levels of the human GSDMB transgene showed a significant spontaneous increase in AHR and a significant spontaneous increase in airway remodeling, with increased smooth muscle mass and increased fibrosis in the absence of airway inflammation. In addition, hGSDMBZp3-Cre mice showed increases in the same remodeling and AHR mediators (TGF-β1, 5-LO) observed in vitro in GSDMB-overexpressing epithelial cells. GSDMB induces TGF-β1 expression via induction of 5-LO, because knockdown of 5-LO in epithelial cells overexpressing GSDMB inhibited TGF-β1 expression. These studies demonstrate that GSDMB, a gene highly linked to asthma but whose function in asthma is previously unknown, regulates AHR and airway remodeling without airway inflammation through a previously unrecognized pathway in which GSDMB induces 5-LO to induce TGF-β1 in bronchial epithelium.

Published
2016

25. Segmental allergen challenge increases levels of airway follistatin-like 1 in patients with asthma

Author

Miller, Marina, Esnault, Stephane, Kurten, Richard C, Kelly, Elizabeth A, Beppu, Andrew, Das, Sudipta, Rosenthal, Peter, Ramsdell, Joe, Croft, Michael, Zuraw, Bruce, Jarjour, Nizar, Hamid, Qutayba, and Broide, David H

Subjects
Biomedical and Clinical Sciences, Immunology, Allergens, Asthma, Case-Control Studies, Female, Follistatin-Related Proteins, Humans, Macrophages, Alveolar, Male, Matrix Metalloproteinase 9, RNA, Messenger, Young Adult, Allergy
Abstract

Segmental allergen challenge induced increased levels of bronchoalveolar (BAL) follistatin like 1 (FSTL1). BAL macrophages both expressed FSTL1, and could be induced by FSTL1 to express MMP9 suggesting a potential role of FSTL1 in remodeling.

Published
2016

27. Fstl1 Promotes Asthmatic Airway Remodeling by Inducing Oncostatin M.

Author

Miller, Marina, Beppu, Andrew, Rosenthal, Peter, Pham, Alexa, Das, Sudipta, Karta, Maya, Song, Dae, Vuong, Christine, Doherty, Taylor, Croft, Michael, Zhang, Xu, Gao, Xiang, Chouiali, Fazila, Hamid, Qutayba, Broide, David, Aceves, Seema, and Zuraw, Bruce

Subjects
Airway Remodeling, Animals, Antibodies, Asthma, Female, Follistatin-Related Proteins, Humans, Macrophages, Male, Mice, Oncostatin M, Signal Transduction
Abstract

Chronic asthma is associated with airway remodeling and decline in lung function. In this article, we show that follistatin-like 1 (Fstl1), a mediator not previously associated with asthma, is highly expressed by macrophages in the lungs of humans with severe asthma. Chronic allergen-challenged Lys-Cre(tg) /Fstl1(Δ/Δ) mice in whom Fstl1 is inactivated in macrophages/myeloid cells had significantly reduced airway remodeling and reduced levels of oncostatin M (OSM), a cytokine previously not known to be regulated by Fstl1. The importance of the Fstl1 induction of OSM to airway remodeling was demonstrated in murine studies in which administration of Fstl1 induced airway remodeling and increased OSM, whereas administration of an anti-OSM Ab blocked the effect of Fstl1 on inducing airway remodeling, eosinophilic airway inflammation, and airway hyperresponsiveness, all cardinal features of asthma. Overall, these studies demonstrate that the Fstl1/OSM pathway may be a novel pathway to inhibit airway remodeling in severe human asthma.

Published
2015

33. Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study

Author

Bourbeau, Jean, Tan, Wan C., FitzGerald, J. Mark, Sin, D.D., Marciniuk, D.D., O'Donnell, D.E., Hernandez, Paul, Chapman, Kenneth R., Cowie, Robert, Aaron, Shawn, Maltais, F., Samet, Jonathon, Puhan, Milo, Hamid, Qutayba, Hogg, James C., Baglole, Carole, Jabet, Carole, Mancino, Palmina, Fortier, Yvan, Sin, Don, Tam, Sheena, Road, Jeremy, Comeau, Joe, Png, Adrian, Coxson, Harvey, Kirby, Miranda, Leipsic, Jonathon, Hague, Cameron, Sadatsafavi, Mohsen, Gershon, Andrea, Li, Pei-Zhi, Duquette, Jean-Francois, Benedetti, Andrea, Jensen, Denis, O'Donnell, Denis, Lo, Christine, Cheng, Sarah, Fung, Cindy, Ferguson, Nancy, Haynes, Nancy, Chuang, Junior, Li, Licong, Bayat, Selva, Wong, Amanda, Alavi, Zoe, Peng, Catherine, Zhao, Bin, Scott-Hsiung, Nathalie, Nadirshaw, Tasha, Latreille, David, Baril, Jacinthe, Labonte, Laura, Chapman, Kenneth, McClean, Patricia, Audisho, Nadeen, Walker, Brandie, Cowie, Ann, Dumonceaux, Curtis, Machado, Lisette, Fulton, Scott, Osterling, Kristen, Vandemheen, Kathy, Pratt, Gay, Bergeron, Amanda, McNeil, Matthew, Whelan, Kate, Maltais, Francois, Brouillard, Cynthia, Marciniuk, Darcy, Clemens, Ron, Baran, Janet, Shorofsky, Matthew, Kimoff, John, Jen, Rachel, Malhotra, Atul, Ayas, Najib, Aaron, Shawn D., Sin, Don D., O’Donnell, Denis E., Maltais, François, Walker, Brandie L., and Kaminska, Marta

Published
2019
Full Text
View/download PDF

35. Assessment of Knowledge, Perceptions, and Attitudes During the Global Mpox Outbreak in June 2022: A Cross-Sectional Study From the United Arab Emirates

Author

Zeidan, Rouba Karen, primary, Shukla, Ankita, additional, Hussein, Amal, additional, AlZubaidi, Hamzah, additional, Temsah, Mohamad-Hani, additional, AlHajjaj, Mohamed S., additional, Al-Bluwi, Najlaa, additional, Awad, Manal, additional, Alsayed, Hawra Ali Hussein, additional, Saheb Sharif-Askari, Narjes, additional, AlHano, Zahraa, additional, Agha, Razan, additional, Hamid, Qutayba, additional, Halwani, Rabih, additional, and Saddik, Basema, additional

Published
2023
Full Text
View/download PDF

37. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

Author

Jia, Guiquan, Erickson, Richard W, Choy, David F, Mosesova, Sofia, Wu, Lawren C, Solberg, Owen D, Shikotra, Aarti, Carter, Richard, Audusseau, Séverine, Hamid, Qutayba, Bradding, Peter, Fahy, John V, Woodruff, Prescott G, Harris, Jeffrey M, Arron, Joseph R, and Group, Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroid-refractory Asthma Study

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Lung, Asthma, Clinical Research, Inflammatory and immune system, Respiratory, Adipokines, Adult, Biomarkers, Breath Tests, Cell Adhesion Molecules, Chitinase-3-Like Protein 1, Eosinophilia, Eosinophils, Female, Humans, Immunoglobulin E, Inflammation, Interleukin-13, Lectins, Logistic Models, Male, Middle Aged, Nitric Oxide, biomarker, sputum, bronchoscopy, eosinophil, T(H)2, IL-13, periostin, IgE, FENO, Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroid-refractory Asthma (BOBCAT) Study Group, Immunology, Allergy
Abstract

BackgroundEosinophilic airway inflammation is heterogeneous in asthmatic patients. We recently described a distinct subtype of asthma defined by the expression of genes inducible by T(H)2 cytokines in bronchial epithelium. This gene signature, which includes periostin, is present in approximately half of asthmatic patients and correlates with eosinophilic airway inflammation. However, identification of this subtype depends on invasive airway sampling, and hence noninvasive biomarkers of this phenotype are desirable.ObjectiveWe sought to identify systemic biomarkers of eosinophilic airway inflammation in asthmatic patients.MethodsWe measured fraction of exhaled nitric oxide (Feno), peripheral blood eosinophil, periostin, YKL-40, and IgE levels and compared these biomarkers with airway eosinophilia in asthmatic patients.ResultsWe collected sputum, performed bronchoscopy, and matched peripheral blood samples from 67 asthmatic patients who remained symptomatic despite maximal inhaled corticosteroid treatment (mean FEV(1), 60% of predicted value; mean Asthma Control Questionnaire [ACQ] score, 2.7). Serum periostin levels are significantly increased in asthmatic patients with evidence of eosinophilic airway inflammation relative to those with minimal eosinophilic airway inflammation. A logistic regression model, including sex, age, body mass index, IgE levels, blood eosinophil numbers, Feno levels, and serum periostin levels, in 59 patients with severe asthma showed that, of these indices, the serum periostin level was the single best predictor of airway eosinophilia (P = .007).ConclusionPeriostin is a systemic biomarker of airway eosinophilia in asthmatic patients and has potential utility in patient selection for emerging asthma therapeutics targeting T(H)2 inflammation.

Published
2012

41. Cell free ACE2 RNA: A potential biomarker of COVID-19 severity

Author

Jalaleddine, Nour, primary, Gaudet, Mellissa, additional, Mogas, Andrea, additional, Hachim, Mahmood, additional, Senok, Abiola, additional, Saheb Sharif-Askari, Narjes, additional, Mahboub, Bassam, additional, Halwani, Rabih, additional, Hamid, Qutayba, additional, and Al Heialy, Saba, additional

Published
2023
Full Text
View/download PDF

45. Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease

Author

Pothoven, Kathryn L., Norton, James E., Suh, Lydia A., Carter, Roderick G., Harris, Kathleen E., Biyasheva, Assel, Welch, Kevin, Shintani-Smith, Stephanie, Conley, David B., Liu, Mark C., Kato, Atsushi, Avila, Pedro C., Hamid, Qutayba, Grammer, Leslie C., III, Peters, Anju T., Kern, Robert C., Tan, Bruce K., and Schleimer, Robert P.

Published
2017
Full Text
View/download PDF

49. Asthma, Eosinophils, and Interleukin-5

Author

Kay, A. Barry, primary, Hamid, Qutayba, additional, Robinson, Douglas S., additional, Bentley, Andrew M., additional, Tsicopoulos, Anne, additional, Ying, Sun, additional, Moqbel, Redwan, additional, Corrigan, Christopher J., additional, and Durham, Stephen R., additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results